Skip to main content Accessibility help
×
Home

Emergence of Community-Associated Methicillin-Resistant Staphylococcus aureus Strains as a Cause of Healthcare-Associated Bloodstream Infections in Korea

  • Sun Hee Park (a1), Chulmin Park (a2), Jin-Hong Yoo (a1), Su-Mi Choi (a1), Jung-Hyun Choi (a1), Hyun-Ho Shin (a2), Dong-Gun Lee (a1), Seungok Lee (a3), JaYoung Kim (a3), So Eun Choi (a4), Young-Mi Kwon (a4) and Wan-Shik Shin (a1)...

Abstract

Background.

The prevalence of community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) strains causing bloodstream infection (BSI) has not been studied in Korea.

Objective.

We sought to determine the prevalence of CA-MRSA strains among isolates recovered from patients with MRSA BSIs and to explore epidemiological changes in Korea. We also sought to evaluate clinical characteristics relevant to the development of healthcare-associated BSIs.

Methods.

We prospectively collected consecutive MRSA isolates from patients with BSI at 4 hospitals from July 1 through November 30, 2007, and we also included MRSA isolates recovered from culture of blood samples collected during a previous year (October 1, 2004 through September 30, 2005) at a different hospital. Molecular typing studies were performed, including pulsed-field gel electrophoresis (PFGE), multilocus sequence typing, Staphylococcus protein A (spa) typing, and staphylococcal cassette chromosome mec (SCCmec) typing. We compared the clinical characteristics and outcomes of patients with healthcare-associated BSI due to CA-MRSA strains with those of patients with healthcare-associated BSI due to healthcare-associated MRSA (HA-MRSA) strains.

Results.

There were 76 cases of MRSA BSI, of which 4 (5.3%) were community-associated and 72 (94.7%) were healthcare-associated. Among the 72 HA-MRSA BSIs, 18 (25%) were community onset, and 54 (75%) were hospital onset. PFGE type D-ST72–spa B-SCCmec type IVA MRSA, the predominant genotype of CA-MRSA in Korea, accounted for 19 (25%) of all 76 MRSA BSIs, including 17 (23.6%) of 72 HA-MRSA BSIs and 11 (20.8%) of 53 hospital-onset HA-MRSA BSIs. Patients with healthcare-associated BSIs due to CA-MRSA strains carrying SCCmec type IVA tended to have fewer healthcare-associated risk factors, compared with patients with healthcare-associated BSIs due to HA-MRSA strains carrying other SCCmec types. The presence of a central venous catheter or other invasive device was the only independent factor differentiating patients infected with hospital-associated genotype strains from patients infected with other strains. Clinical outcomes were similar between both groups.

Conclusions.

CA-MRSA strains are emerging as a major cause of BSI in healthcare settings in Korea. This changing epidemiology of MRSA poses a challenge to public health and infection control in hospital settings.

Copyright

Corresponding author

Department of Internal Medicine, St. Mary's Hospital, 62, Yoido-Dong, Youngdeungpo-Gu, Seoul, Korea150-713 (zenithbr@catholic.ac.kr)

References

Hide All
1.Lo, WT, Lin, WJ, Tseng, MH, Wang, SR, Chu, ML, Wang, CC. Methicillin-resistant Staphylococcus aureus in children, Taiwan. Emerg Infect Dis 2006;12:12671270.
2.Vandenesch, F, Naimi, T, Enright, MC, et al.Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes: worldwide emergence. Emerg Infect Dis 2003;9:978984.
3.Zetola, N, Francis, JS, Nuermberger, EL, Bishai, WR. Community-acquired methicillin-resistant Staphylococcus aureus: an emerging threat. Lancet Infect Dis 2005;5:275286.
4.Fridkin, SK, Hageman, JC, Morrison, M, et al.Methicillin-resistant Staphylococcus aureus disease in three communities. N Engl J Med 2005;352:14361444.
5.Okuma, K, Iwakawa, K, Turnidge, JD, et al.Dissemination of new methicillin-resistant Staphylococcus aureus clones in the community. J Clin Microbiol 2002;40:42894294.
6.Tenover, FC, McDougal, LK, Goering, RV, et al.Characterization of a strain of community-associated methicillin-resistant Staphylococcus aureus widely disseminated in the United States. J Clin Microbiol 2006;44:108118.
7.Naimi, TS, LeDell, KH, Como-Sabetti, K, et al.Comparison of communityand health care-associated methicillin-resistant Staphylococcus aureus infection. JAMA 2003;290:29762984.
8.Choi, SH, Chung, JW. A fatal case of infective endocarditis caused by community—associated methicillin-resistant Staphylococcus aureus ST72 in Korea. Korean J Clin Microbiol 2008;11:129131.
9.Kim, SY, Lee, HS, Kim, JY, et al.A case of acute pyelonephritis caused by community-acquired methicillin-resistant Staphylococcus aureus [in Korean]. Infect Chemother 2007;39:100103.
10.Park, C, Lee, DG, Choi, SM, et al.A case of perianal abscess due to Panton-Valentine Leukocidin positive community-associated methicillin-resistant Staphylococcus aureus: report in Korea and literature review from the far East. Infect Chemother 2008;40:121126.
11.Kim, ES, Song, JS, Lee, HJ, et al.A survey of community-associated methicillin-resistant Staphylococcus aureus in Korea. J Antimicrob Chemother 2007;60:11081114.
12.Kim, HB. Community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) [in Korean]. Korean J Intern Med 2007;72:120130.
13.Park, C, Lee, DG, Kim, SW, et al.Predominance of community-associated methicillin-resistant Staphylococcus aureus strains carrying staphylococcal chromosome cassette mec type IVA in South Korea. J Clin Microbiol 2007;45:40214026.
14.Cha, HY, Moon, DC, Choi, CH, et al.Prevalence of the ST239 clone of methicillin-resistant Staphylococcus aureus and differences in antimicrobial susceptibilities of ST239 and ST5 clones identified in a Korean hospital. J Clin Microbiol 2005;43:36103614.
15.Ko, KS, Kim, YS, Song, JH, et al.Genotypic diversity of methicillin-resistant Staphylococcus aureus isolates in Korean hospitals. Antimicrob Agents Chemother 2005;49:35833585.
16.Jeong, HY, Lee, JE, Choi, BK, et al.Molecular epidemiology of community-associated antimicrobial-resistant Staphylococcus aureus in Seoul, Korea (2003): pervasiveness of multidrug-resistant SCCmec type II methicillin-resistant S. aureus. Microb Drug Resist 2007;13:178185.
17.Ma, SH, Kim, EJ, Lee, JC, Lee, YS. Clinical features and microbial characteristics of community-acquired MRSA staphylococcal scaled skin syndrome [in Korean]. Infect Chemother 2005;37(Supp 2):S232.
18.Cuevas, O, Cercenado, E, Bouza, E, et al.Molecular epidemiology of methicillin-resistant Staphylococcus aureus in Spain: a multicentre prevalence study (2002). Clin Microbiol Infect 2007;13:250256.
19.de A Trindade, P, Pacheco, RL, Costa, SF, et al.Prevalence of SCCmec type IV in nosocomial bloodstream isolates of methicillin-resistant Staphylococcus aureus. J Clin Microbiol 2005;43:34353437.
20.Donnio, PY, Preney, L, Gautier-Lerestif, AL, Avril, JL, Lafforgue, N. Changes in staphylococcal cassette chromosome type and antibiotic resistance profile in methicillin-resistant Staphylococcus aureus isolates from a French hospital over an 11-year period. J Antimicrob Chemother 2004;53:808813.
21.Huang, YH, Tseng, SP, Hu, JM, Tsai, JC, Hsueh, PR, Teng, LJ. Clonal spread of SCCmec type IV methicillin-resistant Staphylococcus aureus between community and hospital. Clin Microbiol Infect 2007;13:717724.
22.Ko, KS, Park, S, Peck, KR, et al.Molecular characterization of methicillin-resistant Staphylococcus aureus spread by neonates transferred from primary obstetrics clinics to a tertiary care hospital in Korea. Infect Control Hosp Epidemiol 2006;27:593597.
23.Popovich, KJ, Weinstein, RA, Hota, B. Are community-associated methicillin-resistant Staphylococcus aureus (MRSA) strains replacing traditional nosocomial MRSA strains? Clin Infect Dis 2008;46:787794.
24.Saiman, L, O’Keefe, M, Graham, PL3rd, et al.Hospital transmission of community-acquired methicillin-resistant Staphylococcus aureus among postpartum women. Clin Infect Dis 2003;37:13131319.
25.Seybold, U, Kourbatova, EV, Johnson, JG, et al.Emergence of community-associated methicillin-resistant Staphylococcus aureus USA300 genotype as a major cause of health care-associated blood stream infections. Clin Infect Dis 2006;42:647656.
26.Gonzalez, BE, Rueda, AM, Shelburne, SA 3rd, Musher, DM, Hamill, RJ, Hulten, KG. Community-associated strains of methicillin-resistant Staphylococcus aureus as the cause of healthcare-associated infection. Infect Control Hosp Epidemiol 2006;27:10511056.
27.Klevens, RM, Morrison, MA, Fridkin, SK, et al.Community-associated methicillin-resistant Staphylococcus aureus and healthcare risk factors. Emerg Infect Dis 2006;12:19911993.
28.Horan, TC, Andrus, M, Dudeck, MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care Setting. Am J Infect Control 2008;36:309332.
29.Mermel, LA, Farr, BM, Sherertz, RJ, et al.Guidelines for the management of intravascular catheter-related infections. Clin Infect Dis 2001;32:12491272.
30.Durack, DT, Lukes, AS, Bright, DK. New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Duke Endocarditis Service. Am J Med 1994;96:200209.
31.Harbarth, S, Rutschmann, O, Sudre, P, Pittet, D. Impact of methicillin resistance on the outcome of patients with bacteremia caused by Staphylococcus aureus. Arch Intern Med 1998;158:182189.
32.Klevens, RM, Morrison, MA, Nadle, J, et al.Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA 2007;298:17631771.
33.Davis, SL, Rybak, MJ, Amjad, M, Kaatz, GW, McKinnon, PS. Characteristics of patients with healthcare-associated infection due to SCCmec type IV methicillin-resistant Staphylococcus aureus. Infect Control Hosp Epidemiol 2006;27:10251031.
34.Clinical and Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibility testing: 17th informational supplement. Wayne, PA: CLSI; 2007:M100-S17.
35.McDougal, LK, Steward, CD, Killgore, GE, Chaitram, JM, McAllister, SK, Tenover, FC. Pulsed-field gel electrophoresis typing of oxacillin-resistant Staphylococcus aureus isolates from the United States: establishing a national database. J Clin Microbiol 2003;41:51135120.
36.Enright, MC, Day, NP, Davies, CE, Peacock, SJ, Spratt, BG. Multilocus sequence typing for characterization of methicillin-resistant and meth-icillin-susceptible clones of Staphylococcus aureus. J Clin Microbiol 2000;38:10081015.
37.Shopsin, B, Gomez, M, Montgomery, SO, et al.Evaluation of protein A gene polymorphic region DNA sequencing for typing of Staphylococcus aureus strains. J Clin Microbiol 1999;37:35563563.
38.Ruppitsch, W, Indra, A, Stoger, A, et al.Classifying spa types in complexes improves interpretation of typing results for methicillin-resistant Staphylococcus aureus. J Clin Microbiol 2006;44:24422448.
39.Staphylococcus aureus database. Available at: http://saureus.mlst.net/. Accessed March 26, 2008.
40.Aires-de-Sousa, M, Boye, K, de Lencastre, H, et al.High interlaboratory reproducibility of DNA sequence-based typing of bacteria in a multi-center study. J Clin Microbiol 2006;44:619621.
41.Ridom SpaServer. Available at: http://www.ridom.de/spaserver. Accessed May 2, 2008.
42.Oliveira, DC, de Lencastre, H. Multiplex PCR strategy for rapid identification of structural types and variants of the mec element in methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 2002;46:21552161.
43.Kim, HB, Jang, HC, Nam, HJ, et al.In vitro activities of 28 antimicrobial agents against Staphylococcus aureus isolates from tertiary-care hospitals in Korea: a nationwide survey. Antimicrob Agents Chemother 2004;48:11241127.
44.Maree, CL, Daum, RS, Boyle-Vavra, S, Matayoshi, K, Miller, LG. Community-associated methicillin-resistant Staphylococcus aureus isolates causing healthcare-associated infections. Emerg Infect Dis 2007;13:236242.
45.Amorim, ML, Faria, NA, Oliveira, DC, et al.Changes in the clonal nature and antibiotic resistance profiles of methicillin-resistant Staphylococcus aureus isolates associated with spread of the EMRSA-15 clone in a tertiary care Portuguese hospital. J Clin Microbiol 2007;45:28812888.
46.Pan, ES, Diep, BA, Carleton, HA, et al.Increasing prevalence of methicillin-resistant Staphylococcus aureus infection in California jails. Clin Infect Dis 2003;37:13841388.
47.de Franchis, R. Evolving consensus in portal hypertension: report of the Baveno IV consensus workshop oh methodology of diagnosis and therapy in portal hypertension. J Hepatol 2005;43:167176.
48.Gines, A, Escorsell, A, Gines, P, et al.Incidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis with ascites. Gastroenterology 1993;105:229236.
49.Laupland, KB, Ross, T, Gregson, DB. Staphylococcus aureus bloodstream infections: risk factors, outcomes, and the influence of methicillin resistance in Calgary, Canada, 2000–2006. J Infect Dis 2008;198:336343.
50.Kaye, KS, Anderson, DJ, Choi, Y, Link, K, Thacker, P, Sexton, DJ. The deadly toll of invasive methicillin-resistant Staphylococcus aureus infection in community hospitals. Clin Infect Dis 2008;46:15681577.
51.Datta, R, Huang, SS. Risk of infection and death due to methicillin-resistant Staphylococcus aureus in long-term carriers. Clin Infect Dis 2008;47:176181.

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed